SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
kaki
Lv1
40 积分
2022-05-18 加入
最近求助
最近应助
互助留言
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia
1天前
已完结
Four-Drug Therapy for Multiple Myeloma
18天前
已完结
Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis
20天前
已关闭
Developments in consolidation and maintenance strategies in post-remission multiple myeloma
4个月前
已完结
Efficacy and Safety Analysis of VRD-PDCE in Treatment-Native Patients with Multiple Extramedullary Plasmacytomas or Plasma Cell Leukemia
8个月前
已完结
Lenalidomide is active for extramedullary disease in refractory multiple myeloma
8个月前
已完结
Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma
8个月前
已完结
Research Progress on Molecular Mechanisms of Resistance to Bortezomib in Multiple Myeloma- Review
1年前
已完结
9. Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
1年前
已完结
How I treat high-risk multiple myeloma
1年前
已完结
没有进行任何应助
感谢
18天前
其他途径寻找了【积分已退回】
20天前
还是to editor的letter不是文章原文
20天前
是to editor的letter,并不是文章原文
20天前
感谢,速度真快,点赞,帮大忙了,么么哒
4个月前
速度真快,帮大忙了,点赞
8个月前
感谢,速度真快
8个月前
感谢,感谢
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论